USRE38341E1 - Method for electrokinetic delivery of medicaments - Google Patents
Method for electrokinetic delivery of medicaments Download PDFInfo
- Publication number
- USRE38341E1 USRE38341E1 US09/472,524 US47252499A USRE38341E US RE38341 E1 USRE38341 E1 US RE38341E1 US 47252499 A US47252499 A US 47252499A US RE38341 E USRE38341 E US RE38341E
- Authority
- US
- United States
- Prior art keywords
- electrode
- individual
- medicament
- applicator electrode
- applicator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
Definitions
- This invention relates generally to the transdermal electrokinetic mass transfer of medication into a diseased tissue, and, more specifically, to a portable apparatus for the iontophoretic delivery of medication across the skin and incorporation of the medication into diseased tissues and blood vessels adjacent to the delivery site.
- the apparatus provides a new method for treating and managing diseases presenting cutaneous lesions.
- Iontophoresis has been employed for several centuries as a means for applying medication locally through a patient's skin and for delivering medicaments to the eyes and ears.
- the application of an electric field to the skin is known to greatly enhance the skin's permeability to various ionic agents.
- the use of iontophoretic transdermal delivery techniques has obviated the need for hypodermic injection for many medicaments, thereby eliminating the concomitant problems of trauma, pain and risk of infection to the patient.
- Iontophoresis involves the application of an electromotive force to drive or repel oppositely charged ions through the dermal layers into a target tissue.
- target tissue include tissues adjacent to the delivery site for localized treatment or tissues remote therefrom in which case the medicament enters into the circulatory system and is transported to a tissue by the blood.
- Positively charged ions are driven into the skin at an anode while negatively charged ions are driven into the skin at a cathode.
- Studies have shown increased skin penetration of drugs at anodic or cathodic electrodes regardless of the predominant molecular ionic charge on the drug. This effect is mediated by polarization and osmotic effects.
- a iontophoretic delivery device employs two electrodes (an anode and a cathode) in conjunction with the patient's skin to form a closed circuit between one of the electrodes (referred to herein alternatively as a “working” or “application” or “applicator” electrode) which is positioned at the delivered site of drug delivery and a passive or “grounding” electrode affixed to a second site on the skin to enhance the rate of penetration of the medicament into the skin adjacent to the applicator electrode.
- the present invention provides a portable iontophoretic medicament delivery apparatus and a unit-dosage medicament-containing applicator electrode which is disposable and adapted for use with the apparatus for self-administering medicament.
- the present invention discloses a portable iontophoretic transdermal or transmucoscal medicament delivery apparatus and a unit dosage medicament applicator electrode adapted for use with the apparatus for the self-administration of a unit dose of a medicament into the skin.
- the apparatus is particularly suited for the localized treatment of herpes infections.
- Recurrent herpetic infections fever blisters or herpes labialis
- the established treatment for recurrent herpetic lesions (oral or genital) has been primarily supportive; including local topical application of anesthesia. Severe cases have been treated with systemic Acyclovir® (Zovirax Burroughs-Wellcome).
- the present invention discloses a portable, user-friendly transdermal delivery device and a method for using the device with Acyclovir® [ 2 - hydroxyethoxy ( methyl ) guanine (or similar antiviral agent) to greatly benefit these afflicted patients.
- Acyclovir® 2 - hydroxyethoxy ( methyl ) guanine (or similar antiviral agent) to greatly benefit these afflicted patients.
- the present inventor has constructed embodiments of this device and conducted human clinical trials which clearly demonstrate improved therapeutic efficacy using iontophoretically administered antiviral agents when compared to unassisted topical application of the agent.
- the iontophoretic medicament delivery apparatus is easily maneuverable and operable when hand-held.
- the iontophoretic medicament delivery apparatus is battery powered and conveniently transported by a person.
- the iontophoretic medicament delivery apparatus employs a tactile electrode which is in electrical contact with the skin of a user's hand when the apparatus is held in the user's hand, obviating the need for a separate grounding electrode connector or wire:
- the iontophoretic medicament delivery apparatus is adapted to be operable with a disposable medicament containing applicator electrode which applicator electrode includes an absorbent, inert, non-corrosive portion containing a therapeutic agent.
- the disposable iontophoretic medicament applicator electrode include indicator means operable for enabling a user to determine when the medicament within the removable applicator electrode has been released in delivery and/or depleted.
- circuitry employed in the disposable iontophoretic medicament applicator include current limiting means operable for limiting the electrical current flowing between the surface of the applicator and the skin to less than about one milliampere per square centimeters of application electrode skin-contacting surface.
- the iontophoretic medicament delivery apparatus employs a disposable application electrode which conducts the electrical current to the tissue through the solution in which the medicament is dissolved.
- the improved disposable iontophoretic medicament applicator is inexpensive, safe to use and greatly increases the therapeutic efficacy of a medicament administered thereby.
- the apparatus in accordance with the present invention provides a means for topically administering medicament directly and with high efficiency into a diseased tissue thereby providing a novel method for treating clinical conditions presenting mucocutaneous symptoms and particularly mucocutaneous Herpes Simplex viral eruptions and settle associated therewith.
- FIG. 1 is a side elevational plan view of the iontophoretic medicament delivery apparatus showing the circumferential tactile ground electrode on the outer surface of the base housing and a disposable iontophoretic application electrode;
- FIG. 2 is a side elevational view of the disposable non-reusable iontophoretic application electrode with a portion broken away to view the medicament dose packet;
- FIG. 1 shows, in side elevation, a preferred embodiment of the hand-held iontophoretic transdermal medicament delivery apparatus of the present invention.
- the apparatus indicated generally by the numeral 10 , has an elongate base assembly 11 the major portion of which is preferably formed of plastic and shaped to conform to and comfortably fit within a users hand.
- An applicator electrode module 12 containing a unit dose of medicament 23 , is releasably attached to a applicator electrode receptacle 14 on the distal end of the base assembly 11 .
- the application electrode 12 is preferably a “clip-on” type of electrode similar in configuration to an electrocardiogram electrode.
- electrically conductive elements such as wires and busses are presented as heavy lines.
- a wire 16 provides electrical connection between the applicator electrode receptacle 14 and wire 18 within the neck 15 of the base assembly 11 .
- Connecting wire 18 provides electrical connection between the wire 16 and the current driver unit 19 housed within the base assembly 11 .
- a conductive tactile electrode 20 forms a portion of the exterior skin-contacting surface of the base assembly 11 preferably circumferentially enclosing a portion of the base housing or it may be interrupted or discontinuous on the outer surface.
- the tactile electrode 20 is in electrical communication with the cathode 24 C of battery 24 by means of a buss 17 and conductive urging spring 25 which secures the battery in position within the base assembly 11 .
- a user must have skin contact with the tactile electrode 20 for the unit to operate.
- Current driver 19 underlies the cathodic (ground) tactile electrode 20 and is electrically connected via wire 21 to a voltage multiplier 22 .
- the voltage multiplier 22 receives low voltage power from the anode 24 a of the battery power source 24 and increases the available voltage for presentation to the application electrode 12 .
- the battery 24 a self- contained electrical power source, is preferably a size AA or AAA. Battery 24 is held in place by an electrically conductive biasing spring 25 and ensures that electrical power is available at the application electrode 12 when the user grasps and holds the base housing 11 of the apparatus 10 thereby touching the cathodic tactile electrode 20 .
- the application electrode 12 and the tactile electrode 20 thus form a closed circuit in series with the user's skin.
- the polarity of the working electrode 12 is preferably unidirectional to promote the above described penetration without requiring a separate grounding electrode.
- the working application electrode 12 will be described in greater detail below.
- the base assembly 11 of apparatus 10 serves as a housing to the aforesaid components as a handle.
- the portion of the base assembly 11 exclusive of the tactile electrode, is preferably made of a plastic such as polyethylene, acrylonitrile, butadiene, styrene or similar durable plastic.
- the battery portion 24 is connected to a voltage multiplier 22 which steps up the voltage supplied by the battery 24 and applies the stepped up voltage to the current driver 19 .
- Current driver 19 presents a defined current and voltage output at the application electrode 12 the value of the current, which may be empirically determined being sufficient to drive the medicament through the porous, open-celled material 27 (FIG.
- the circuitry limits the maximum current available to the application electrode to preferably to less than about one milliampere per two square centimeters of the skin-contacting surface area 13 of the application electrode 12 .
- the current level can vary from about 0.1 to about 1.2 milliamps. Currents ranging between 0.1 ma to 5 ma have been used clinically by the present inventor, but the higher currents caused the user minor discomfort and, with chronic use over time, may produce untoward effects.
- FIG. 2 shows a preferred embodiment of the iontophoretic medicament-containing application electrode 12 .
- the application electrode 12 is preferably disposable and non-reusable and is suitable, for example, for transdermally delivering antiviral agents such as Acyclovir® for the treatment of cold sores or genital herpes.
- the size of the skin-contacting surface 13 of application electrode 12 may vary to accommodate specific clinical applications.
- the application electrode 12 is detachably housed within a recess within the receptacle 14 which recess presents an electrically conductive interior surface to complete the electrical flow path from the connecting wires 18 and 16 to a conductive element 29 within the application electrode.
- the electrical current from the current driver 19 is conducted through conductive inner surface of the application electrode receptacle 14 to the electrically conductive element 29 within the applicator electrode which element 29 is in electrical contact with the inner surface of the receptacle in contact therewith to drive the medicament 23 or treatment agent through the open-celled sponge-like like matrix material 27 and through the user's skin (not shown).
- the medicament or treatment agent 23 is contained within a rupturable polymer reservoir 26 until dispensed during treatment. A slight exertion of pressure or squeezing of the reservoir 26 against reservoir puncture means 28 releases the medicament or treatment agent into an open-celled sponge-like material 27 within the application electrode for iontophoretic delivery into the patient's skin.
- Medicament 23 release can occur at the time of application or upon peruse compression of the electrode 12 .
- Application electrode 12 can be advantageously designed to include a stripping portion adapted so that upon removal of the application electrode 12 from the electrode receptacle 14 a protruding stripping portion (not shown) scrapingly strips the conductive coating from the conductive support arm 29 to prevent reuse of the disposable electrode 12 .
- Application electrode 12 is intentionally packaged with a single dose packet or reservoir 26 of treatment agent or medicament 23 .
- the reservoir 26 can include a coloring agent, such as iodine, which turns dark blue upon contact with starch in the open-celled material to visibly indicate that the unit dose encapsulation has been used.
- suitable coloring agents can include pH indicators, wet saturation indicators or oxidizable pigments.
- the open-celled sponge-like material 27 i.e., a substrate, surrounding reservoir 26 should be inert to the medicament or treatment agent being employed, as well as being non-corrosive and stable when in contact with the treatment agent.
- Suitable materials include plastic pads, such as polyethylene, paper or cotton, porous ceramics, open-celled porous polytetrafluoroethylene, polyurethane and other inert plastics, and open-celled silicone rubber, such as may be employed with vertically aligned medicament-containing tubes.
- a typical medicament that can be contained within the rupturable polymer reservoir 26 is xylocaine or similar topical anesthetic.
- the disposable electrode 12 possesses the advantages of preventing leaching or migration of the medicament from within the rupturable polymer reservoir, no attendant loss of efficacy, a long shelf life and little or no electrode corrosion.
- a suitable electrical control circuit for use in the iontophoretic medicament delivery apparatus 12 is shown in U.S. patent application, Ser. No. 07/579,799, filed Sep. 10, 1990, now U.S. Pat. No. 5,160,316 and hereby specifically incorporated by reference herein in pertinent part.
- the inventor has conducted a clinical study using a prototype iontophoretic device in accordance with the present invention for the treatment of cold sores.
- the clinical response was promising.
- a second independent, qualified investigator, a board-certified Urologist conducted a study using the present apparatus and method for treating male genital herpes lesions with encouraging results.
- Table 1 summarizes data (discussed below) supporting the claim to unexpected clinical benefits treating disease with this novel method.
- the method and medicament application device when used together for treating these common, embarrassing, and previously not easily-treatable ailments provide surprising advantages.
- the embodiment of the device shown in FIG. 1 and described hereinabove is a improvement over the prototype used in the clinical study, which was a larger unit, not user friendly, which required physically connecting wires to the patient's body which created anxiety, and could not be used without attending personnel. Notwithstanding design, the apparatus used in the clinical study summarized in Table 1 employed electronics similar to the apparatus described herein and was used to optimize the clinical performance of the embodiment 12 of the device described herein.
- Table 2 The results for the control group are summarized in Table 2.
- ZOVIRAX® Acyclovir® ointment
- IUDR STOXIL®
- the lesion was evaluated in 24 hours. In 92% of the iontophoretically treated cases (>70 lesions treated) a major response was noted. A major response was categorized by resolution of pain in ⁇ 6 hours and lesion crusted and healing within 24 hours. The normal course of cold sores involves an average period of 10-12 days before resolution and healing occurs.
- the present apparatus and clinical method for treatment of mucocutaneous Herpes Simplex (type I and Type II) eruptions presented herein have been described and performed with excellent results. This novel user friendly apparatus in combination with the disclosed clinical treatment method presents a very effective new treatment for Herpes Simplex eruptions.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
TABLE 1 |
STAGE I TREATMENT RESULTS |
RESPONSE | IUDR | ACYCLOVIR ® | TOTALS | ||
No response | 1 | 1 | 2 | ||
Some response | 1 | 3 | 4 | ||
|
26 | 42 | 68 | ||
TABLE 2 |
CONTROL GROUP RESULTS |
No response | Some resp. | Major resp. | ||
IUDR | |||
Treated lesion | 0 | 0 | 7 |
Control lesion | 5 | 2 | 0 |
ACYCLOVIR ® | |||
Treated lesion | 0 | 0 | 1 |
Control lesion | 1 | 0 | 0 |
Claims (51)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/472,524 USRE38341E1 (en) | 1996-05-08 | 1999-12-27 | Method for electrokinetic delivery of medicaments |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/646,853 US5676648A (en) | 1996-05-08 | 1996-05-08 | Iontophoretic drug delivery apparatus and method for use |
US08/868,499 US5879323A (en) | 1996-05-08 | 1997-06-04 | Method for iontophoretic delivery of antiviral agents |
US09/472,524 USRE38341E1 (en) | 1996-05-08 | 1999-12-27 | Method for electrokinetic delivery of medicaments |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/868,499 Reissue US5879323A (en) | 1996-05-08 | 1997-06-04 | Method for iontophoretic delivery of antiviral agents |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE38341E1 true USRE38341E1 (en) | 2003-12-09 |
Family
ID=24594728
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/646,853 Ceased US5676648A (en) | 1996-05-08 | 1996-05-08 | Iontophoretic drug delivery apparatus and method for use |
US08/868,499 Ceased US5879323A (en) | 1996-05-08 | 1997-06-04 | Method for iontophoretic delivery of antiviral agents |
US09/417,106 Expired - Lifetime USRE38000E1 (en) | 1996-05-08 | 1999-10-13 | Electrokinetic drug delivery apparatus |
US09/472,524 Expired - Lifetime USRE38341E1 (en) | 1996-05-08 | 1999-12-27 | Method for electrokinetic delivery of medicaments |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/646,853 Ceased US5676648A (en) | 1996-05-08 | 1996-05-08 | Iontophoretic drug delivery apparatus and method for use |
US08/868,499 Ceased US5879323A (en) | 1996-05-08 | 1997-06-04 | Method for iontophoretic delivery of antiviral agents |
US09/417,106 Expired - Lifetime USRE38000E1 (en) | 1996-05-08 | 1999-10-13 | Electrokinetic drug delivery apparatus |
Country Status (6)
Country | Link |
---|---|
US (4) | US5676648A (en) |
EP (1) | EP0956091A4 (en) |
JP (1) | JP2000510012A (en) |
AU (1) | AU728510C (en) |
CA (1) | CA2253671C (en) |
WO (1) | WO1997041919A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030018295A1 (en) * | 2000-05-31 | 2003-01-23 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
WO2005084748A1 (en) * | 2004-03-04 | 2005-09-15 | Hadasit Medical Research Services & Development Company Ltd. | Safe device for iontophoretic delivery of drugs |
US20050251024A1 (en) * | 2004-05-05 | 2005-11-10 | Mario Ammirati | System and method for controlled delivery of a target location within an internal body tissue |
US20060003996A1 (en) * | 2002-06-17 | 2006-01-05 | Stephen Roth | Intralesional treatment of psoriasis |
US20070276318A1 (en) * | 2006-05-26 | 2007-11-29 | Mit, Llp | Iontosonic-microneedle applicator apparatus and methods |
US20100094249A1 (en) * | 2008-10-09 | 2010-04-15 | Ty Caswell | Wound treatment apparatus and methods |
US8328788B2 (en) | 1999-03-12 | 2012-12-11 | Nitric Biotherapeutics, Inc. | Methods and systems for electrokinetic delivery of a substance |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6956032B1 (en) * | 1986-04-18 | 2005-10-18 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
US5676648A (en) | 1996-05-08 | 1997-10-14 | The Aps Organization, Llp | Iontophoretic drug delivery apparatus and method for use |
US6385487B1 (en) * | 1996-05-08 | 2002-05-07 | Biophoretic Therapeutic Systems, Llc | Methods for electrokinetic delivery of medicaments |
US5908401A (en) * | 1996-05-08 | 1999-06-01 | The Aps Organization, Llp | Method for iontophoretic delivery of antiviral agents |
US6775569B2 (en) * | 1997-11-05 | 2004-08-10 | Hisamitsu Pharmaceutical Co., Inc. | Electroporation device for in vivo delivery of therapeutic agents |
US5938658A (en) * | 1997-12-02 | 1999-08-17 | Tu; Hosheng | Device and methods for treating canker sores by RF ablation |
USRE37796E1 (en) | 1997-12-16 | 2002-07-23 | Biophoretic Therapeutic Systems, Llc | Methods for iontophoretic delivery of antiviral agents |
AU1622999A (en) | 1997-12-17 | 1999-07-05 | Alza Corporation | Iontophoresis with programmed adjustment of electric current |
FR2773320B1 (en) * | 1998-01-05 | 2000-03-03 | Optisinvest | DEVICE FOR INTRAOCULAR TRANSFER OF ACTIVE PRODUCTS BY IONTOPHORESIS |
US6104952A (en) * | 1998-01-07 | 2000-08-15 | Tu; Lily Chen | Devices for treating canker sores, tissues and methods thereof |
US5968005A (en) * | 1998-01-07 | 1999-10-19 | Tu; Hosheng | Devices and means for treating canker sores |
IL123290A (en) | 1998-02-13 | 2001-12-23 | Hadasit Med Res Service | Iontophoretic device |
US6023639A (en) * | 1998-05-01 | 2000-02-08 | Hakky; Said | Non-invasive bodily fluid withdrawal and monitoring system |
JP2002520101A (en) * | 1998-07-13 | 2002-07-09 | ジェネトロニクス、インコーポレーテッド | Method and apparatus for localized delivery of electrically assisted cosmetic agents |
JP4297401B2 (en) * | 1998-09-15 | 2009-07-15 | トランスポート・ファーマシューティカルズ・インコーポレイテッド | Drug delivery electrode by ion osmosis therapy |
US6148231A (en) * | 1998-09-15 | 2000-11-14 | Biophoretic Therapeutic Systems, Llc | Iontophoretic drug delivery electrodes and method |
US6500165B1 (en) | 1998-10-29 | 2002-12-31 | Steven R. Frank | Active antisepsis device |
US6553253B1 (en) * | 1999-03-12 | 2003-04-22 | Biophoretic Therapeutic Systems, Llc | Method and system for electrokinetic delivery of a substance |
US7127285B2 (en) * | 1999-03-12 | 2006-10-24 | Transport Pharmaceuticals Inc. | Systems and methods for electrokinetic delivery of a substance |
US6461331B1 (en) | 1999-05-21 | 2002-10-08 | Minimed Inc. | Device and method for infusion of small molecule insulin mimetic materials |
US6728573B1 (en) | 2000-02-23 | 2004-04-27 | Iomed, Inc. | Ocular iontophoretic apparatus handle |
US6641591B1 (en) | 1999-08-26 | 2003-11-04 | John H. Shadduck | Instruments and techniques for controlled removal of epidermal layers |
GB2372705A (en) * | 2000-11-03 | 2002-09-04 | Kieron Loy | A hand-held self-administered iontophoretic drug applicator with roller-ball skin electrode |
US6738662B1 (en) | 2000-11-21 | 2004-05-18 | Steven R. Frank | Electrolytic substance infusion device |
US6579276B2 (en) * | 2001-01-22 | 2003-06-17 | Iomed, Inc. | Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the same |
US6712805B2 (en) * | 2001-01-29 | 2004-03-30 | Ultra Sonic Tech Llc | Method and apparatus for intradermal incorporation of microparticles containing encapsulated drugs using low frequency ultrasound |
JP2002263199A (en) * | 2001-03-06 | 2002-09-17 | Yoshiyasu Ito | Device for iontophoresis |
BR0116990A (en) * | 2001-04-27 | 2004-03-02 | Biophoretic Therapeutics Syste | Method and system for electrokinetic release of a substance |
AU2007216942B2 (en) * | 2001-04-27 | 2010-05-13 | Nitric Biotherapeutics, Inc. | Method and system for electrokinetic delivery of a substance |
US6953446B2 (en) * | 2001-09-21 | 2005-10-11 | Iomed, Inc. | Method and device for the iontophoretic delivery of a drug |
US9084879B2 (en) * | 2002-01-22 | 2015-07-21 | Encore Medical Asset Corporation | Method and device for the iontophoretic delivery of a drug |
US6766199B2 (en) * | 2002-10-10 | 2004-07-20 | Proventure (Far East), Limited | Skin/hair treatment method and system |
SI1718360T1 (en) | 2004-02-12 | 2016-09-30 | ProVenture (Far East) Limited Unit B, 3/F, Eton Building | Skin/hair treatment system |
CA2591267C (en) * | 2004-04-30 | 2012-04-10 | Eyegate Pharma S.A. | Irritation-reducing ocular ionthophoretic device |
FR2869531B1 (en) * | 2004-04-30 | 2006-07-14 | Optis France Sa Sa | OCULAR IONTOPHORESIS DEVICE REDUCING IRRITATION |
US20070066934A1 (en) * | 2005-09-19 | 2007-03-22 | Transport Pharmaceuticals, Inc. | Electrokinetic delivery system and methods therefor |
US20070185432A1 (en) * | 2005-09-19 | 2007-08-09 | Transport Pharmaceuticals, Inc. | Electrokinetic system and method for delivering methotrexate |
US20070232983A1 (en) * | 2005-09-30 | 2007-10-04 | Smith Gregory A | Handheld apparatus to deliver active agents to biological interfaces |
US8099162B2 (en) | 2005-11-29 | 2012-01-17 | Eyegate Pharma, S.A.S. | Ocular iontophoresis device |
US8048089B2 (en) | 2005-12-30 | 2011-11-01 | Edge Systems Corporation | Apparatus and methods for treating the skin |
US20070191757A1 (en) * | 2006-02-16 | 2007-08-16 | Biodel Inc. | Method and Device for Sublingual Drug Delivery Using Iontophoresis |
US8343116B2 (en) | 2008-01-04 | 2013-01-01 | Edge Systems Corporation | Apparatus and method for treating the skin |
US9566088B2 (en) | 2006-03-29 | 2017-02-14 | Edge Systems Llc | Devices, systems and methods for treating the skin |
US10172644B2 (en) | 2006-03-29 | 2019-01-08 | Edge Systems Llc | Devices, systems and methods for treating the skin |
US20070282246A1 (en) * | 2006-06-05 | 2007-12-06 | Mit, Llp | Iontosonic-microneedle biosensor apparatus and methods |
KR100829425B1 (en) | 2007-07-06 | 2008-05-15 | 주식회사 엘지생활건강 | Iontophoresis device |
US9056193B2 (en) | 2008-01-29 | 2015-06-16 | Edge Systems Llc | Apparatus and method for treating the skin |
US8814836B2 (en) | 2008-01-29 | 2014-08-26 | Edge Systems Llc | Devices, systems and methods for treating the skin using time-release substances |
MX2011006925A (en) | 2008-12-31 | 2011-07-28 | Eyegate Pharma S A S | System and method for ocular iontophoresis with buffering. |
US8882819B2 (en) | 2011-02-16 | 2014-11-11 | Richard Crowder | Handheld device for treating oral ulcers and sores |
JP5730137B2 (en) * | 2011-06-08 | 2015-06-03 | 日立マクセル株式会社 | Beauty equipment |
EP2753395B1 (en) * | 2011-09-09 | 2020-07-29 | International Scientific Pty Ltd | Method and device for delivery of substances |
RU2645637C2 (en) * | 2012-01-16 | 2018-02-26 | Суисс Спа Систем Лтд. | Manual electrical skin care device |
EP2967633B1 (en) | 2013-03-15 | 2018-04-25 | Edge Systems LLC | Devices for treating the skin |
US10238812B2 (en) | 2013-03-15 | 2019-03-26 | Edge Systems Llc | Skin treatment systems and methods using needles |
US20150265825A1 (en) * | 2014-03-21 | 2015-09-24 | L'oreal | Combined sonic and iontophoretic skin care device |
EP4324414A3 (en) | 2014-12-23 | 2024-05-01 | HydraFacial LLC | Devices and methods for treating the skin using a rollerball or a wicking member |
US10179229B2 (en) | 2014-12-23 | 2019-01-15 | Edge Systems Llc | Devices and methods for treating the skin using a porous member |
US11241357B2 (en) | 2015-07-08 | 2022-02-08 | Edge Systems Llc | Devices, systems and methods for promoting hair growth |
AU2016369628B2 (en) * | 2015-12-17 | 2021-06-10 | Hg Medical Technologies Llc | Electro kinetic transdermal and trans mucosal delivery accelerator device |
USD1016615S1 (en) | 2021-09-10 | 2024-03-05 | Hydrafacial Llc | Container for a skin treatment device |
Citations (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US279524A (en) | 1883-06-19 | Thimble | ||
US484522A (en) * | 1892-10-18 | Edward h | ||
US600290A (en) * | 1898-03-08 | Therapeutic electrode | ||
US2126070A (en) * | 1932-04-29 | 1938-08-09 | Wappler Frederick Charles | Electrotherapy |
US2834344A (en) | 1954-07-22 | 1958-05-13 | Lion Brush K K | Device for penetrating teeth with fluoride |
US3019787A (en) * | 1960-10-05 | 1962-02-06 | Joe J Simmons | Apparatus for electrolytic dental desensitization |
US3048170A (en) | 1960-11-08 | 1962-08-07 | Lemos Albano | Electrical devices for the application of fluid to the gums |
US3107672A (en) | 1958-05-27 | 1963-10-22 | Ewald Rose | Electrical apparatus for cosmetic treatment of the skin |
AT232642B (en) | 1959-07-31 | 1964-03-25 | Ewald Rose | Electrical device for cosmetic self-treatment of the skin |
US3163166A (en) | 1961-04-28 | 1964-12-29 | Colgate Palmolive Co | Iontophoresis apparatus |
FR1445703A (en) | 1965-06-03 | 1966-07-15 | Advanced ionization apparatus | |
US3298368A (en) | 1964-04-24 | 1967-01-17 | Charos Peter | Heated cream applicator gloves |
US3520297A (en) * | 1967-01-31 | 1970-07-14 | Chemway Corp | Iontophoretic toothbrush |
US3645260A (en) | 1970-07-17 | 1972-02-29 | Health Systems Inc | Dental desensitizer |
US3716054A (en) * | 1970-08-11 | 1973-02-13 | W Porter | Apparatus for applying medication to teeth and body tissue |
US3831598A (en) | 1972-09-28 | 1974-08-27 | I Tice | Sterile anesthetic instruments |
US4325367A (en) | 1977-06-13 | 1982-04-20 | Robert Tapper | Iontophoretic treatment apparatus |
US4383529A (en) | 1980-11-03 | 1983-05-17 | Wescor, Inc. | Iontophoretic electrode device, method and gel insert |
US4474570A (en) | 1981-07-10 | 1984-10-02 | Kabushikikaisya Advance Kaihatsu Kenkyujo | Iontophoresis device |
US4510939A (en) | 1982-12-22 | 1985-04-16 | Biosonics, Inc. | Means for transferring electrical energy to and from living tissue |
US4665921A (en) * | 1984-05-28 | 1987-05-19 | Teranishi Electric Works, Ltd. | High potential generating toothbrush |
US4689039A (en) * | 1985-07-19 | 1987-08-25 | Ken Hayashibara | Electrotherapeutic apparatus for iontophoresis |
US4702732A (en) | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
US4747819A (en) | 1984-10-29 | 1988-05-31 | Medtronic, Inc. | Iontophoretic drug delivery |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US4838273A (en) | 1979-04-30 | 1989-06-13 | Baxter International Inc. | Medical electrode |
US4913148A (en) | 1985-07-31 | 1990-04-03 | Hepax Limited | Method for the treatment of herpes simplex and herpes zoster |
US4919648A (en) | 1983-08-18 | 1990-04-24 | Drug Delivery Systems Inc. | High tack drug patch |
US4953565A (en) | 1986-11-26 | 1990-09-04 | Shunro Tachibana | Endermic application kits for external medicines |
US4957480A (en) | 1988-02-02 | 1990-09-18 | Universal Health Products, Inc. | Method of facial toning |
US4979938A (en) * | 1989-05-11 | 1990-12-25 | Iomed, Inc. | Method of iontophoretically treating acne, furuncles and like skin disorders |
US4997418A (en) | 1988-04-21 | 1991-03-05 | C. P. Chambers | Epidermal iontophoresis device |
US5037381A (en) | 1990-07-27 | 1991-08-06 | Bock C Randolph | Electrically assisted transdermal transport device and method for renewing the device |
US5042975A (en) | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
US5090402A (en) * | 1987-08-12 | 1992-02-25 | L'oreal | Massaging appliance |
US5133352A (en) | 1990-04-12 | 1992-07-28 | Kent, Lathrop And Johnston | Method for treating herpes simplex |
US5160316A (en) | 1990-09-10 | 1992-11-03 | Henley Julian L | Iontophoretic drug delivery apparatus |
US5162042A (en) | 1988-07-05 | 1992-11-10 | Alza Corporation | Electrotransport transdermal system |
US5169384A (en) * | 1991-08-16 | 1992-12-08 | Bosniak Stephen L | Apparatus for facilitating post-traumatic, post-surgical, and/or post-inflammatory healing of tissue |
US5203768A (en) | 1991-07-24 | 1993-04-20 | Alza Corporation | Transdermal delivery device |
US5250022A (en) | 1990-09-25 | 1993-10-05 | Rutgers, The State University Of New Jersey | Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose |
US5279543A (en) | 1988-01-29 | 1994-01-18 | The Regents Of The University Of California | Device for iontophoretic non-invasive sampling or delivery of substances |
US5284471A (en) | 1989-09-25 | 1994-02-08 | Becton, Dickinson And Company | Electrode and method used for iontophoresis |
US5298017A (en) | 1992-12-29 | 1994-03-29 | Alza Corporation | Layered electrotransport drug delivery system |
US5310404A (en) | 1992-06-01 | 1994-05-10 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
US5312326A (en) | 1992-06-02 | 1994-05-17 | Alza Corporation | Iontophoretic drug delivery apparatus |
US5314502A (en) | 1990-03-30 | 1994-05-24 | Alza Corporation | Iontophoretic delivery device |
US5331979A (en) | 1992-07-27 | 1994-07-26 | Henley Julian L | Iontophoretic cigarette substitute |
EP0617979A1 (en) | 1993-04-02 | 1994-10-05 | Juan Jose Villar Faro | Manual device for carrying out an iontophoresis treatment |
US5354321A (en) | 1990-10-10 | 1994-10-11 | Mario Berger | Patch arrangement for galvanic treatment |
US5360440A (en) | 1992-03-09 | 1994-11-01 | Boston Scientific Corporation | In situ apparatus for generating an electrical current in a biological environment |
US5362308A (en) | 1990-09-25 | 1994-11-08 | Rutgers, The State University Of New Jersey | Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes |
US5362307A (en) | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
US5374241A (en) | 1989-07-21 | 1994-12-20 | Iomed, Inc. | Electrodes for iontophoresis |
US5374242A (en) | 1991-12-03 | 1994-12-20 | Alza Corporation | Iontophoretic delivery device and power supply therefor |
US5376107A (en) | 1990-03-05 | 1994-12-27 | Kowa Co., Ltd. | Electrotherapeutic device |
US5391195A (en) | 1991-04-17 | 1995-02-21 | B.V. Optische Industrie De Oude Delft | Device for carrying out an iontophoresis treatment on a patient |
US5395310A (en) | 1988-10-28 | 1995-03-07 | Alza Corporation | Iontophoresis electrode |
US5413590A (en) | 1991-07-17 | 1995-05-09 | Innovative Medical Devices (Uk) Ltd. | Skin treatment device |
US5415629A (en) | 1993-09-15 | 1995-05-16 | Henley; Julian L. | Programmable apparatus for the transdermal delivery of drugs and method |
US5421816A (en) | 1992-10-14 | 1995-06-06 | Endodermic Medical Technologies Company | Ultrasonic transdermal drug delivery system |
US5441936A (en) | 1993-12-07 | 1995-08-15 | Houghten Pharmaceuticals, Inc. | Antiviral peptides |
US5443441A (en) * | 1993-03-05 | 1995-08-22 | De Claviere; Anne Marie | Apparatus and method for transdermal delivery of cosmetic compositions |
US5458569A (en) | 1993-06-08 | 1995-10-17 | Becton Dickinson And Company | Wearable iontophoresis system |
US5464387A (en) | 1991-07-24 | 1995-11-07 | Alza Corporation | Transdermal delivery device |
US5466217A (en) | 1992-06-02 | 1995-11-14 | Alza Corporation | Iontophoretic drug delivery apparatus |
US5470349A (en) | 1991-06-18 | 1995-11-28 | Courage & Khazaka Electronic Gmbh | Device for treating inflammatory skin changes in the initial stage, and method for using same |
US5494679A (en) | 1992-01-22 | 1996-02-27 | Becton Dickinson And Company | Molecules for iontophoretic delivery |
US5501705A (en) | 1988-10-31 | 1996-03-26 | Fakhri; Omar | Method for the treatment of psoriasis with electric current |
US5514167A (en) | 1994-10-24 | 1996-05-07 | Mgb Technologies Corporation | Hand holdable human skin treatment apparatus |
US5562607A (en) | 1995-01-18 | 1996-10-08 | Alza Corporation | Electrotransport device having reusable controller power saver |
US5589563A (en) | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
US5603693A (en) * | 1993-09-10 | 1997-02-18 | Asulab S.A. | Three part device for the transdermic administration of drugs by electrophoresis or iontophoresis |
US5607691A (en) | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
US5607461A (en) | 1995-10-20 | 1997-03-04 | Nexmed, Inc. | Apparatus and method for delivering electrical stimulus to tissue |
US5618275A (en) | 1995-10-27 | 1997-04-08 | Sonex International Corporation | Ultrasonic method and apparatus for cosmetic and dermatological applications |
US5658247A (en) | 1993-04-07 | 1997-08-19 | Henley; Julian L. | Ionosonic drug delivery apparatus |
US5668170A (en) | 1994-07-13 | 1997-09-16 | Alza Corporation | Composition and method enhancing transdermal electrotransport agent delivery |
US5676648A (en) | 1996-05-08 | 1997-10-14 | The Aps Organization, Llp | Iontophoretic drug delivery apparatus and method for use |
US5688233A (en) * | 1992-08-17 | 1997-11-18 | Genetronics, Inc. | Electronincorporation enhanced transdermal delivery of molecules |
US5697896A (en) | 1994-12-08 | 1997-12-16 | Alza Corporation | Electrotransport delivery device |
US5700457A (en) | 1994-01-21 | 1997-12-23 | Dixon; Gary W. | Processed product for skin and hair treatment |
US5711761A (en) | 1984-10-29 | 1998-01-27 | Alza Corporation | Iontophoretic drug delivery |
US5713846A (en) * | 1996-09-27 | 1998-02-03 | Becton Dickinson And Company | Iontophoretic drug delivery system, including method for activating same for attachment to patient |
US5722397A (en) | 1993-11-15 | 1998-03-03 | Altea Technologies, Inc. | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
US5725817A (en) | 1992-11-12 | 1998-03-10 | Implemed, Inc. | Iontophoretic structure for medical devices |
US5733255A (en) | 1995-10-18 | 1998-03-31 | Novartis Finance Corporation | Thermopile powered transdermal drug delivery device |
US5755750A (en) | 1995-11-13 | 1998-05-26 | University Of Florida | Method and apparatus for selectively inhibiting activity in nerve fibers |
US5788666A (en) | 1995-06-15 | 1998-08-04 | Empi, Inc. | Iontophoresis electrode |
US5795321A (en) | 1994-09-30 | 1998-08-18 | Becton Dickinson And Company | Iontophoretic drug delivery system, including removable controller |
US5797867A (en) | 1996-09-27 | 1998-08-25 | Becton Dickinson And Company | Iontophoretic drug delivery system, including method for activating same for attachment to patient |
US5830175A (en) | 1995-09-28 | 1998-11-03 | Becton Dickinson And Company | Iontophoretic drug delivery system, including disposable patch |
US5840057A (en) * | 1995-01-27 | 1998-11-24 | Aloisi; Alessandro | Device for iontophoretic physiotherapy with frozen medicament crystals |
US5846217A (en) | 1997-07-29 | 1998-12-08 | Iomed, Inc. | Iontophoretic bioelectrode and method of using same |
US5882676A (en) | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates |
US5908401A (en) | 1996-05-08 | 1999-06-01 | The Aps Organization, Llp | Method for iontophoretic delivery of antiviral agents |
US5919155A (en) | 1992-12-31 | 1999-07-06 | Alza Corporation | Electrotransport system having flexible connector means |
US5931859A (en) | 1998-09-30 | 1999-08-03 | Burke; Robert E. | Facial toning system |
US5935598A (en) | 1996-06-19 | 1999-08-10 | Becton Dickinson Research Center | Iontophoretic delivery of cell adhesion inhibitors |
US5961482A (en) | 1986-07-25 | 1999-10-05 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
US5968006A (en) | 1997-11-04 | 1999-10-19 | Genetronics, Inc. | Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes |
US5968005A (en) | 1998-01-07 | 1999-10-19 | Tu; Hosheng | Devices and means for treating canker sores |
US5983130A (en) | 1995-06-07 | 1999-11-09 | Alza Corporation | Electrotransport agent delivery method and apparatus |
US6004309A (en) | 1990-03-30 | 1999-12-21 | Alza Corporation | Method and apparatus for controlled environment electrotransport |
US6004547A (en) | 1997-09-29 | 1999-12-21 | Focal, Inc. | Apparatus and method for local application of polymeric material to tissue |
US6006130A (en) * | 1994-06-17 | 1999-12-21 | Hisamitsu Pharmaceutical Co. | Iontophoresis electrode and iontophoresis device using the electrode |
US6018679A (en) | 1997-01-29 | 2000-01-25 | Novartis Finance Corp. | Iontophoretic transdermal delivery and control of adverse side-effects |
US6023639A (en) | 1998-05-01 | 2000-02-08 | Hakky; Said | Non-invasive bodily fluid withdrawal and monitoring system |
US6032073A (en) | 1995-04-07 | 2000-02-29 | Novartis Ag | Iontophoretic transdermal system for the administration of at least two substances |
US6038485A (en) | 1997-06-12 | 2000-03-14 | Axelgaard Manufacturing Co., Ltd. | Current-controlling electrode |
US6041253A (en) | 1995-12-18 | 2000-03-21 | Massachusetts Institute Of Technology | Effect of electric field and ultrasound for transdermal drug delivery |
US6041252A (en) | 1995-06-07 | 2000-03-21 | Ichor Medical Systems Inc. | Drug delivery system and method |
US6048545A (en) * | 1994-06-24 | 2000-04-11 | Biozone Laboratories, Inc. | Liposomal delivery by iontophoresis |
US6057374A (en) | 1994-11-14 | 2000-05-02 | Alza Corporation | Composition, device, and method for electrotransport agent delivery |
US6101411A (en) | 1998-09-24 | 2000-08-08 | Newsome; David A. | Dilation enhancer |
US6167302A (en) * | 1996-04-16 | 2000-12-26 | Iomed, Inc. | Device for transcutaneous administration of medications using iontophoresis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB299553A (en) | 1927-08-17 | 1928-11-01 | Harold Bright | Improved construction of instrument for treating diseases of the human body |
EP0419473A1 (en) * | 1988-11-28 | 1991-04-03 | Innofinance Altalanos Innovacios Penzintetet | Iontophoresis apparatus |
-
1996
- 1996-05-08 US US08/646,853 patent/US5676648A/en not_active Ceased
-
1997
- 1997-05-05 AU AU27527/97A patent/AU728510C/en not_active Ceased
- 1997-05-05 JP JP09540126A patent/JP2000510012A/en active Pending
- 1997-05-05 EP EP97921503A patent/EP0956091A4/en not_active Ceased
- 1997-05-05 CA CA002253671A patent/CA2253671C/en not_active Expired - Fee Related
- 1997-05-05 WO PCT/US1997/007590 patent/WO1997041919A1/en not_active Application Discontinuation
- 1997-06-04 US US08/868,499 patent/US5879323A/en not_active Ceased
-
1999
- 1999-10-13 US US09/417,106 patent/USRE38000E1/en not_active Expired - Lifetime
- 1999-12-27 US US09/472,524 patent/USRE38341E1/en not_active Expired - Lifetime
Patent Citations (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US484522A (en) * | 1892-10-18 | Edward h | ||
US600290A (en) * | 1898-03-08 | Therapeutic electrode | ||
US279524A (en) | 1883-06-19 | Thimble | ||
US2126070A (en) * | 1932-04-29 | 1938-08-09 | Wappler Frederick Charles | Electrotherapy |
US2834344A (en) | 1954-07-22 | 1958-05-13 | Lion Brush K K | Device for penetrating teeth with fluoride |
US3107672A (en) | 1958-05-27 | 1963-10-22 | Ewald Rose | Electrical apparatus for cosmetic treatment of the skin |
AT232642B (en) | 1959-07-31 | 1964-03-25 | Ewald Rose | Electrical device for cosmetic self-treatment of the skin |
US3019787A (en) * | 1960-10-05 | 1962-02-06 | Joe J Simmons | Apparatus for electrolytic dental desensitization |
US3048170A (en) | 1960-11-08 | 1962-08-07 | Lemos Albano | Electrical devices for the application of fluid to the gums |
US3163166A (en) | 1961-04-28 | 1964-12-29 | Colgate Palmolive Co | Iontophoresis apparatus |
US3298368A (en) | 1964-04-24 | 1967-01-17 | Charos Peter | Heated cream applicator gloves |
FR1445703A (en) | 1965-06-03 | 1966-07-15 | Advanced ionization apparatus | |
US3520297A (en) * | 1967-01-31 | 1970-07-14 | Chemway Corp | Iontophoretic toothbrush |
US3645260A (en) | 1970-07-17 | 1972-02-29 | Health Systems Inc | Dental desensitizer |
US3716054A (en) * | 1970-08-11 | 1973-02-13 | W Porter | Apparatus for applying medication to teeth and body tissue |
US3831598A (en) | 1972-09-28 | 1974-08-27 | I Tice | Sterile anesthetic instruments |
US4325367A (en) | 1977-06-13 | 1982-04-20 | Robert Tapper | Iontophoretic treatment apparatus |
US4838273A (en) | 1979-04-30 | 1989-06-13 | Baxter International Inc. | Medical electrode |
US4383529A (en) | 1980-11-03 | 1983-05-17 | Wescor, Inc. | Iontophoretic electrode device, method and gel insert |
US4474570A (en) | 1981-07-10 | 1984-10-02 | Kabushikikaisya Advance Kaihatsu Kenkyujo | Iontophoresis device |
US4510939A (en) | 1982-12-22 | 1985-04-16 | Biosonics, Inc. | Means for transferring electrical energy to and from living tissue |
US4919648A (en) | 1983-08-18 | 1990-04-24 | Drug Delivery Systems Inc. | High tack drug patch |
US4665921A (en) * | 1984-05-28 | 1987-05-19 | Teranishi Electric Works, Ltd. | High potential generating toothbrush |
US4747819A (en) | 1984-10-29 | 1988-05-31 | Medtronic, Inc. | Iontophoretic drug delivery |
US5711761A (en) | 1984-10-29 | 1998-01-27 | Alza Corporation | Iontophoretic drug delivery |
US4702732A (en) | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
US4689039A (en) * | 1985-07-19 | 1987-08-25 | Ken Hayashibara | Electrotherapeutic apparatus for iontophoresis |
US4913148A (en) | 1985-07-31 | 1990-04-03 | Hepax Limited | Method for the treatment of herpes simplex and herpes zoster |
US5961482A (en) | 1986-07-25 | 1999-10-05 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
US5042975A (en) | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
US4953565A (en) | 1986-11-26 | 1990-09-04 | Shunro Tachibana | Endermic application kits for external medicines |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US5090402A (en) * | 1987-08-12 | 1992-02-25 | L'oreal | Massaging appliance |
US5279543A (en) | 1988-01-29 | 1994-01-18 | The Regents Of The University Of California | Device for iontophoretic non-invasive sampling or delivery of substances |
US4957480A (en) | 1988-02-02 | 1990-09-18 | Universal Health Products, Inc. | Method of facial toning |
US4997418A (en) | 1988-04-21 | 1991-03-05 | C. P. Chambers | Epidermal iontophoresis device |
US5162042A (en) | 1988-07-05 | 1992-11-10 | Alza Corporation | Electrotransport transdermal system |
US5395310A (en) | 1988-10-28 | 1995-03-07 | Alza Corporation | Iontophoresis electrode |
US5501705A (en) | 1988-10-31 | 1996-03-26 | Fakhri; Omar | Method for the treatment of psoriasis with electric current |
US5362307A (en) | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
US4979938A (en) * | 1989-05-11 | 1990-12-25 | Iomed, Inc. | Method of iontophoretically treating acne, furuncles and like skin disorders |
US5558632A (en) | 1989-07-21 | 1996-09-24 | Iomed, Inc. | Electrodes for iontophoresis |
US5374241A (en) | 1989-07-21 | 1994-12-20 | Iomed, Inc. | Electrodes for iontophoresis |
US5284471A (en) | 1989-09-25 | 1994-02-08 | Becton, Dickinson And Company | Electrode and method used for iontophoresis |
US5376107A (en) | 1990-03-05 | 1994-12-27 | Kowa Co., Ltd. | Electrotherapeutic device |
US6004309A (en) | 1990-03-30 | 1999-12-21 | Alza Corporation | Method and apparatus for controlled environment electrotransport |
US5314502A (en) | 1990-03-30 | 1994-05-24 | Alza Corporation | Iontophoretic delivery device |
US5133352A (en) | 1990-04-12 | 1992-07-28 | Kent, Lathrop And Johnston | Method for treating herpes simplex |
US5037381A (en) | 1990-07-27 | 1991-08-06 | Bock C Randolph | Electrically assisted transdermal transport device and method for renewing the device |
US5160316A (en) | 1990-09-10 | 1992-11-03 | Henley Julian L | Iontophoretic drug delivery apparatus |
US5250022A (en) | 1990-09-25 | 1993-10-05 | Rutgers, The State University Of New Jersey | Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose |
US5362308A (en) | 1990-09-25 | 1994-11-08 | Rutgers, The State University Of New Jersey | Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes |
US5354321A (en) | 1990-10-10 | 1994-10-11 | Mario Berger | Patch arrangement for galvanic treatment |
US5391195A (en) | 1991-04-17 | 1995-02-21 | B.V. Optische Industrie De Oude Delft | Device for carrying out an iontophoresis treatment on a patient |
US5470349A (en) | 1991-06-18 | 1995-11-28 | Courage & Khazaka Electronic Gmbh | Device for treating inflammatory skin changes in the initial stage, and method for using same |
US5413590A (en) | 1991-07-17 | 1995-05-09 | Innovative Medical Devices (Uk) Ltd. | Skin treatment device |
US5464387A (en) | 1991-07-24 | 1995-11-07 | Alza Corporation | Transdermal delivery device |
US5203768A (en) | 1991-07-24 | 1993-04-20 | Alza Corporation | Transdermal delivery device |
US5169384A (en) * | 1991-08-16 | 1992-12-08 | Bosniak Stephen L | Apparatus for facilitating post-traumatic, post-surgical, and/or post-inflammatory healing of tissue |
US5374242A (en) | 1991-12-03 | 1994-12-20 | Alza Corporation | Iontophoretic delivery device and power supply therefor |
US5494679A (en) | 1992-01-22 | 1996-02-27 | Becton Dickinson And Company | Molecules for iontophoretic delivery |
US5360440A (en) | 1992-03-09 | 1994-11-01 | Boston Scientific Corporation | In situ apparatus for generating an electrical current in a biological environment |
US5589563A (en) | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
US5310404A (en) | 1992-06-01 | 1994-05-10 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
US5466217A (en) | 1992-06-02 | 1995-11-14 | Alza Corporation | Iontophoretic drug delivery apparatus |
US5312326A (en) | 1992-06-02 | 1994-05-17 | Alza Corporation | Iontophoretic drug delivery apparatus |
US5607691A (en) | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
US5331979A (en) | 1992-07-27 | 1994-07-26 | Henley Julian L | Iontophoretic cigarette substitute |
US5688233A (en) * | 1992-08-17 | 1997-11-18 | Genetronics, Inc. | Electronincorporation enhanced transdermal delivery of molecules |
US5421816A (en) | 1992-10-14 | 1995-06-06 | Endodermic Medical Technologies Company | Ultrasonic transdermal drug delivery system |
US5725817A (en) | 1992-11-12 | 1998-03-10 | Implemed, Inc. | Iontophoretic structure for medical devices |
US5298017A (en) | 1992-12-29 | 1994-03-29 | Alza Corporation | Layered electrotransport drug delivery system |
US5919155A (en) | 1992-12-31 | 1999-07-06 | Alza Corporation | Electrotransport system having flexible connector means |
US5443441A (en) * | 1993-03-05 | 1995-08-22 | De Claviere; Anne Marie | Apparatus and method for transdermal delivery of cosmetic compositions |
EP0617979A1 (en) | 1993-04-02 | 1994-10-05 | Juan Jose Villar Faro | Manual device for carrying out an iontophoresis treatment |
US5667487A (en) * | 1993-04-07 | 1997-09-16 | Henley; Julian L. | Ionosonic drug delivery apparatus |
US5658247A (en) | 1993-04-07 | 1997-08-19 | Henley; Julian L. | Ionosonic drug delivery apparatus |
US5458569A (en) | 1993-06-08 | 1995-10-17 | Becton Dickinson And Company | Wearable iontophoresis system |
US5603693A (en) * | 1993-09-10 | 1997-02-18 | Asulab S.A. | Three part device for the transdermic administration of drugs by electrophoresis or iontophoresis |
US5415629A (en) | 1993-09-15 | 1995-05-16 | Henley; Julian L. | Programmable apparatus for the transdermal delivery of drugs and method |
US5722397A (en) | 1993-11-15 | 1998-03-03 | Altea Technologies, Inc. | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
US5441936A (en) | 1993-12-07 | 1995-08-15 | Houghten Pharmaceuticals, Inc. | Antiviral peptides |
US5700457A (en) | 1994-01-21 | 1997-12-23 | Dixon; Gary W. | Processed product for skin and hair treatment |
US6006130A (en) * | 1994-06-17 | 1999-12-21 | Hisamitsu Pharmaceutical Co. | Iontophoresis electrode and iontophoresis device using the electrode |
US6048545A (en) * | 1994-06-24 | 2000-04-11 | Biozone Laboratories, Inc. | Liposomal delivery by iontophoresis |
US5668170A (en) | 1994-07-13 | 1997-09-16 | Alza Corporation | Composition and method enhancing transdermal electrotransport agent delivery |
US5795321A (en) | 1994-09-30 | 1998-08-18 | Becton Dickinson And Company | Iontophoretic drug delivery system, including removable controller |
US5514167A (en) | 1994-10-24 | 1996-05-07 | Mgb Technologies Corporation | Hand holdable human skin treatment apparatus |
US6057374A (en) | 1994-11-14 | 2000-05-02 | Alza Corporation | Composition, device, and method for electrotransport agent delivery |
US5697896A (en) | 1994-12-08 | 1997-12-16 | Alza Corporation | Electrotransport delivery device |
US5562607A (en) | 1995-01-18 | 1996-10-08 | Alza Corporation | Electrotransport device having reusable controller power saver |
US5840057A (en) * | 1995-01-27 | 1998-11-24 | Aloisi; Alessandro | Device for iontophoretic physiotherapy with frozen medicament crystals |
US6032073A (en) | 1995-04-07 | 2000-02-29 | Novartis Ag | Iontophoretic transdermal system for the administration of at least two substances |
US5882676A (en) | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates |
US6041252A (en) | 1995-06-07 | 2000-03-21 | Ichor Medical Systems Inc. | Drug delivery system and method |
US5983130A (en) | 1995-06-07 | 1999-11-09 | Alza Corporation | Electrotransport agent delivery method and apparatus |
US5788666A (en) | 1995-06-15 | 1998-08-04 | Empi, Inc. | Iontophoresis electrode |
US5830175A (en) | 1995-09-28 | 1998-11-03 | Becton Dickinson And Company | Iontophoretic drug delivery system, including disposable patch |
US5733255A (en) | 1995-10-18 | 1998-03-31 | Novartis Finance Corporation | Thermopile powered transdermal drug delivery device |
US5607461A (en) | 1995-10-20 | 1997-03-04 | Nexmed, Inc. | Apparatus and method for delivering electrical stimulus to tissue |
US5618275A (en) | 1995-10-27 | 1997-04-08 | Sonex International Corporation | Ultrasonic method and apparatus for cosmetic and dermatological applications |
US5755750A (en) | 1995-11-13 | 1998-05-26 | University Of Florida | Method and apparatus for selectively inhibiting activity in nerve fibers |
US6041253A (en) | 1995-12-18 | 2000-03-21 | Massachusetts Institute Of Technology | Effect of electric field and ultrasound for transdermal drug delivery |
US6167302A (en) * | 1996-04-16 | 2000-12-26 | Iomed, Inc. | Device for transcutaneous administration of medications using iontophoresis |
US5908401A (en) | 1996-05-08 | 1999-06-01 | The Aps Organization, Llp | Method for iontophoretic delivery of antiviral agents |
US5879323A (en) | 1996-05-08 | 1999-03-09 | The Aps Organization, Llp | Method for iontophoretic delivery of antiviral agents |
US5676648A (en) | 1996-05-08 | 1997-10-14 | The Aps Organization, Llp | Iontophoretic drug delivery apparatus and method for use |
US5935598A (en) | 1996-06-19 | 1999-08-10 | Becton Dickinson Research Center | Iontophoretic delivery of cell adhesion inhibitors |
US5961483A (en) | 1996-06-19 | 1999-10-05 | Sage; Burton H. | Iontophoretic delivery of cell adhesion inhibitors |
US5797867A (en) | 1996-09-27 | 1998-08-25 | Becton Dickinson And Company | Iontophoretic drug delivery system, including method for activating same for attachment to patient |
US5713846A (en) * | 1996-09-27 | 1998-02-03 | Becton Dickinson And Company | Iontophoretic drug delivery system, including method for activating same for attachment to patient |
US6018679A (en) | 1997-01-29 | 2000-01-25 | Novartis Finance Corp. | Iontophoretic transdermal delivery and control of adverse side-effects |
US6038485A (en) | 1997-06-12 | 2000-03-14 | Axelgaard Manufacturing Co., Ltd. | Current-controlling electrode |
US5846217A (en) | 1997-07-29 | 1998-12-08 | Iomed, Inc. | Iontophoretic bioelectrode and method of using same |
US6004547A (en) | 1997-09-29 | 1999-12-21 | Focal, Inc. | Apparatus and method for local application of polymeric material to tissue |
US5968006A (en) | 1997-11-04 | 1999-10-19 | Genetronics, Inc. | Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes |
US5968005A (en) | 1998-01-07 | 1999-10-19 | Tu; Hosheng | Devices and means for treating canker sores |
US6023639A (en) | 1998-05-01 | 2000-02-08 | Hakky; Said | Non-invasive bodily fluid withdrawal and monitoring system |
US6101411A (en) | 1998-09-24 | 2000-08-08 | Newsome; David A. | Dilation enhancer |
US5931859A (en) | 1998-09-30 | 1999-08-03 | Burke; Robert E. | Facial toning system |
Non-Patent Citations (55)
Title |
---|
"A Method of Antibiotic Administration in the Burn Patient," Rapperport et al.; Plastic and Reconstructive Surgery, vol. 36, No. 5, pp. 547-552. |
"A Pilot Study of Iontophoretic Cisplatin Chemotherapy of Basal and Squamous Cell Carcinomas of the Skin," Chang et al., Arch. Dermatol., vol. 129, pp. 425-427, Apr. 1993. |
"Acyclovir and Vidarabine Monophosphate: Comparison of Iontophoretic and Intravenous Administration for the Treatment of HSV-1 Stromal Keratitis," Hill et al., The American Journal of Medicine, Acyclovir Symposium, pp. 300-304. |
"Anesthesia of the Human Tympanic Membrane by Iontophoresis of a Local Anesthetic," Comeau et al. The Laryngoscope, 88: 1978, pp. 277-285. |
"Antibiotic Iontophoresis in the Treatment of Ear Chondritis," LaForest et al., Physical Therapy, vol. 58, No. 1, Jan. 1978, pp. 32-34. |
"Antiherpesviral and Anticellular Effects of 1-beta-D-Arabinofuranosyl-E-5-(2-Halogenovinyl) Uracils," Machida et al., Antimicrobial Agents and Chemotherapy, Jul. 1981, pp. 47-52. |
"Azelaic Acid 20% Cream (AZELEX(R)) and the Medical Management of Acne Vulgaris," Gibson, Dermatology Nursing, vol. 9, No. 5, pp. 339-344. |
"Azelaic Acid: Potential as a General Antitumoural Agent," Breathnach, Medical Hypotheses (1999) 52(3) 221-226. |
"Common Cold" Virus is Near, Haney, The Associated Press, Jan. 15, 2000. |
"Conductivity of Drugs Used for Iontophoresis," Gangarosa et al., Journal of Pharmaceutical Sciences, vol. 67, No. 10, pp. 1439-1443, Oct. 1978. |
"Early Application of Topical 15% Idoxuridine n Dimethyl Sulfoxide Shortens the Course of Herpes Simplex Labialis: A Multicenter Placebo-Controlled Trial," Spruance et al., The Journal of Infectious Diseases, 1990; vol. 161; pp. 191-197. |
"Eczemia/Atopic Dermatitis," American Academy of Dermatology, 1987, Revised 1991, 1993, 1995. |
"Effect of Iontophoretic and Topical Application of Antiviral Agents in Treatment of Experimental HSV-1 Keratitis in Rabbits," Kwon et al., Investigative Opthalmology & Visual Science, vol. 18, No. 9, pp. 984-988, Sep. 1979. |
"Efficacy and Safety of Azelaic Acid and Glycolic Acid Combination Therapy Compared with Tretinoin Therapy for Acne," Spellman et al., Clinical Therapeutics, vol. 20, No. 4, 1998. |
"Electrophoretic Evaluation of the Mobility of Drugs Suitable for Iontophoresis," Kamath et al., Meth. Find., Exp. Clin. Pharmacol., 1995, 17(4): pp. 227-232. |
"Electrorepulsion Versus Electroosmosis: Effect of pH on the Iontophoretic Flux of 5-Fluorouracil," Merino et al., Pharmaceutical Research, vol. 16, No. 6 (1999). |
"Gelatin-stabilised Microemulsion-Based Oranogels: Rheology and Application in Iontophoretic Transdermal Drug Delivery," Kantaria et al., Journal of Controlled Release 60 (1999) 355-365. |
"Herpes Simplex," American Academy of Dermatology. |
"How Modern Iontophoresis Can Improve Your Practice," Gangarosa et al.; Oral Surgery, No. 10, Report 2135, Oct. 1982, pp. 1027-1038. |
"Infection with Herpes-Simplex Viruses 1 and 2," Nahmias et al.; The New England Journal of Medicine, pp. 667-674, Sep. 27, 1973. |
"Ionotophoresis and Herpes Labialis," Boxhall et al.; The Medical Journal of Australia, May 26, 1984, pp. 686-687. |
"Iontophoresis Enhances the Transport of Acyclovir Through Nude Mouse Skin by Electrorepulsion and Electroosmosis," Volpato et al., Pharmaceutical Research, vol. 12, No. 11, pp. 1623-1627, 1995. |
"Iontophoresis of Vidarabine Monophosphate for Herpes Orolabialis," Gangarosa et al.; The Journal of Infectious Diseases, vol. 154, No. 6, pp. 930-934, Dec. 1986. |
"Iontophoresis: Applications in Transdermal Medication Delivery," Costello et al.; Physical Therapy, vol. 75, No. 6, pp. 104/554-113/563, Jun. 1995. |
"Iontophoresis: Electrorepulsion and Electroosmosis," Guy et al., Journal of Controlled Release 64 (2000) 129-132. |
"Iontophoretic Application of Adenine Arabinoside Monophosphate for the Treatment of Herpes Simplex Virus Type 2 Skin Infections in Hairless Mice," Gangarosa, The Journal of Infectious Diseases, vol. 140, No. 6, pp. 1014, Dec. 1979. |
"Iontophoretic Application of Adenine Arabinoside Monophosphate to Herpes Simplex Virus Type 1-Infected Hairless Mouse Skin," Park et al.; Antimicrobial Agents and Chemotherapy, vol. 14, No. 4, Oct., 1978, pp. 605-608. |
"Iontophoretic Application of Antiviral Chemotherapeutic Agents," Hill et al., Annals New York Academy of Sciences, pp. 604-612. |
"Iontophoretic Application of Antiviral Drugs," Gangarosa et al., Proceedings of an International Symposium held in Tokushima City, Japan, pp. 200-204, Jul. 27-30, 1981. |
"Iontophoretic Application of Drugs," Waud, J. Appl. Physiol. 23(1), 1967, pp. 128-130. |
"Iontophoretic Application of Idoxuridine for Recurrent Herpes Labialis: Report of Preliminary Chemical Trials," Gangarosa et al.; Meth. And Find. Exptl. Clin. Pharmacol. 1(2), pp. 105-109 (1979). |
"Iontophoretic Assistance of 5-Iodo-2'-Deoxyuridine Penetration into Neonatal Mouse Skin and Effects of DNA Synthesis," Gangarosa et al., Society for Experimental Biology and Medicine, pp. 439-443, 1977. |
"Iontophoretic Treatment of Herpetic Whitlow," Gangarosa et al., Arch. Phys. Med. Rehabil., vol. 70, Apr. 1989. |
"Iontophoretic Treatment of Oral Herpes," Henley et al.; Laryngoscope, vol. 94, No. 1, pp. 118-121, Jan. 1984. |
"Iontrophoresis for Enhancing Penetration of Dermatologic and Antiviral Drugs," Gangarosa et al., Journal of Dermatology, vol. 22, No. 11, pp. 865-875, Nov. 1995. |
"Iotonphoresis for Surface Local Anesthesia,"Gangarosa, JADA, vol. 88, pp. 125-128, Jan. 1974. |
"New Medicines Move to Eradicate Acne," Hemphill, The New York Times, Feb. 29, 2000. |
"Ocular Iontophoresis," Hill et al. Paper, Louisiana State University Medical Center, School of Medicine, New Orleans, Louisiana, pp. 331-354. |
"Passive versus Electrotransport-Facilitated Transdermal Absorption of Ketorolac," Park et al.; Clinical Pharmacology & Therapeutics, vol. 63, No. 3, pp. 303-314. |
"Postherpetic Neuralgia," Baron et al.; Brain (1993), 116, pp. 1477-1496. |
"Psoriasis,"American Academy of Dermatology, 1994. |
"Skin Cancer: An Undeclared Epidemic," American Academy of Dermatology, 1988, Revised, 1989, 1993, 1994. |
"Soriudine Versus Acyclovir for Treatment of Dermatomal Herpes Zoster in Human Immunodeficiency Virus-Infected Patients: Results from a Randomized, Controlled Clinical Trial," Gnann et al., Antimicrobial Agents and Chemotherapy, vol. 42, No. 5, May 1998, pp. 1139-1145. |
"Sorivudine: A Promising Drug for the Treatment of Varicella-Zoster Virus Infection," Whitley, Neurology 1995; 45 (Supp. 8), pp. S73-S75. |
"The Natural History of Recurrent Herpes Simplex Labialis," Spruance et al.; The New England Journal of Medicine, vol. 297, No. 2, pp. 69-75, Jul. 14, 1977. |
"The Quantity and Distribution of Radiolabeled Dexamethasone Delivered to Tissue by Iontophoresis," Glass et al.; International Journal of Dermatology, vol. 19, Nov. 1980, pp. 519-525. |
"Thymine Arabinoside (Ara-T) Topical and Iontophoretic Applications for Herpes Simplex Virus Type 1 and Type 2 Skin Infections in Hairless Mice," Hill et al., Meth. And Find. Exptl. Clin. Pharmacol. 6(1), pp. 17-20, 1984. |
"Transdermal Drug Delivery by Passive Diffusion and Iontophoresis: A Review," Singh et al., Medicinal Research Reviews, vol. 13, No. 5, pp. 569-621 (1993). |
"Treatment of Common Cutaneous Herpes Simplex Virus Infections," Emmert, American Family Physician, vol. 61, No. 6, Mar. 15, 2000, pp. 1697-1704. |
"Treatment of Mucocutaneous Herpes Simplex Virus Infections Unresponsive to Acyclovir with Topical Foscarnet Cream in AIDS Patients: A Phase I/II Study," Javaly et al., Journal of Acquired Immune Deficiency Syndromes 21:301-306. |
"Warts," American Academy of Dermatology, American Academy of Dermatology, 1997, Revised 1991, 1993. |
"Antiherpesviral and Anticellular Effects of 1-β-D-Arabinofuranosyl-E-5-(2-Halogenovinyl) Uracils," Machida et al., Antimicrobial Agents and Chemotherapy, Jul. 1981, pp. 47-52. |
"Azelaic Acid 20% Cream (AZELEX®) and the Medical Management of Acne Vulgaris," Gibson, Dermatology Nursing, vol. 9, No. 5, pp. 339-344. |
"Iontophoretic Assistance of 5-Iodo-2′-Deoxyuridine Penetration into Neonatal Mouse Skin and Effects of DNA Synthesis," Gangarosa et al., Society for Experimental Biology and Medicine, pp. 439-443, 1977. |
Physical Enhancement of Dermatologic Drug Delivery: Iontophoresis and Phonophoresis: Kassan et al.; Journal of the American Academy of Dermatology, Apr. 1996, pp. 657-666. |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8328788B2 (en) | 1999-03-12 | 2012-12-11 | Nitric Biotherapeutics, Inc. | Methods and systems for electrokinetic delivery of a substance |
US8352024B2 (en) * | 2000-03-10 | 2013-01-08 | Nitric Biotherapeutics, Inc. | Electrokinetic delivery system for self-administration of medicaments and methods therefor |
US20030018295A1 (en) * | 2000-05-31 | 2003-01-23 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
US6735470B2 (en) * | 2000-05-31 | 2004-05-11 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
US20060003996A1 (en) * | 2002-06-17 | 2006-01-05 | Stephen Roth | Intralesional treatment of psoriasis |
WO2005084748A1 (en) * | 2004-03-04 | 2005-09-15 | Hadasit Medical Research Services & Development Company Ltd. | Safe device for iontophoretic delivery of drugs |
US8666486B2 (en) | 2004-03-04 | 2014-03-04 | Hadasit Medical Research Services & Development Limited | Safe device for iontophoretic delivery of drugs |
US9555238B2 (en) | 2004-03-04 | 2017-01-31 | Hadasit Medical Research Services & Development Limited | Safe device for iontophoretic delivery of drugs |
US20050251024A1 (en) * | 2004-05-05 | 2005-11-10 | Mario Ammirati | System and method for controlled delivery of a target location within an internal body tissue |
US7706873B2 (en) | 2004-05-05 | 2010-04-27 | Mario Ammirati | System and method for controlled delivery of a therapeutic agent to a target location within an internal body tissue |
US20070276318A1 (en) * | 2006-05-26 | 2007-11-29 | Mit, Llp | Iontosonic-microneedle applicator apparatus and methods |
US20100094249A1 (en) * | 2008-10-09 | 2010-04-15 | Ty Caswell | Wound treatment apparatus and methods |
Also Published As
Publication number | Publication date |
---|---|
EP0956091A4 (en) | 2001-10-31 |
CA2253671C (en) | 2007-07-10 |
USRE38000E1 (en) | 2003-02-25 |
CA2253671A1 (en) | 1997-11-13 |
US5879323A (en) | 1999-03-09 |
US5676648A (en) | 1997-10-14 |
WO1997041919A1 (en) | 1997-11-13 |
AU2752797A (en) | 1997-11-26 |
EP0956091A1 (en) | 1999-11-17 |
AU728510C (en) | 2001-10-25 |
JP2000510012A (en) | 2000-08-08 |
AU728510B2 (en) | 2001-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE38341E1 (en) | Method for electrokinetic delivery of medicaments | |
US5908401A (en) | Method for iontophoretic delivery of antiviral agents | |
US6385487B1 (en) | Methods for electrokinetic delivery of medicaments | |
USRE37796E1 (en) | Methods for iontophoretic delivery of antiviral agents | |
US6895271B2 (en) | Iontophoretic drug delivery electrodes and method | |
US5160316A (en) | Iontophoretic drug delivery apparatus | |
US6553253B1 (en) | Method and system for electrokinetic delivery of a substance | |
US5540669A (en) | Iontophoretic drug delivery system and method for using same | |
US5795321A (en) | Iontophoretic drug delivery system, including removable controller | |
Garg et al. | Iontophoresis: drug delivery system by applying an electrical potential across the skin | |
US5919156A (en) | Iontophoretic drug delivery system, including unit for dispensing patches | |
AU763197B2 (en) | Iontophoretic drug delivery electrodes | |
EP0783345A1 (en) | Iontophoretic drug delivery system, including disposable patch and reusable, removable controller | |
WO1996010441A9 (en) | Iontophoretic drug delivery system, including disposable patch and reusable, removable controller | |
EP1390099B1 (en) | System for electrokinetic delivery of a substance | |
CA2561340A1 (en) | Electrically assisted delivery system for administration of ionized active agents | |
AU2001257289A1 (en) | Method and system for electrokinetic delivery of a substance | |
AU2007216942A1 (en) | Method and system for electrokinetic delivery of a substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TRANSPORT PHARMACEUTICALS, INC., PENNSYLVANIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOPHORETIC THERAPEUTIC SYSTEMS, LLC;REEL/FRAME:016621/0042 Effective date: 20050929 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, CONNECTICUT Free format text: SECURITY AGREEMENT;ASSIGNOR:TRANSPORT PHARMACEUTICALS, INC.;REEL/FRAME:022529/0922 Effective date: 20090410 |
|
AS | Assignment |
Owner name: NITRIC BIOTHERAPEUTICS, INC., PENNSYLVANIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TRANSPORT PHARMACEUTICALS, INC.;REEL/FRAME:023456/0269 Effective date: 20091030 Owner name: TRANSPORT PHARMACEUTICALS, INC., MASSACHUSETTS Free format text: TERMINATION AND RELEASE OF SECURITY INTEREST RECORDED AT REEL 022529, FRAME 0922;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION;REEL/FRAME:023456/0389 Effective date: 20091030 Owner name: TRANSPORT PHARMACEUTICALS, INC., MASSACHUSETTS Free format text: SECURITY AGREEMENT;ASSIGNOR:NITRIC BIOTHERAPEUTICS, INC.;REEL/FRAME:023456/0433 Effective date: 20091030 Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, ILLINOIS Free format text: ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY;ASSIGNOR:TRANSPORT PHARMACEUTICALS, INC.;REEL/FRAME:023456/0493 Effective date: 20091030 |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: NITRIC BIOTHERAPEUTICS, INC., PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION;REEL/FRAME:026097/0089 Effective date: 20110404 |